562 related articles for article (PubMed ID: 28219181)
1. [Immunotherapy for head and neck squamous cell carcinoma].
Chen J; Chen M; Wu HT
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 52(2):143-147. PubMed ID: 28219181
[TBL] [Abstract][Full Text] [Related]
2. [Head and neck cancer : promising results of immunotherapy].
Sivade A; Bensaid D; Monnier Y; Shabafrouz K; Bouchaab H; Cristina V
Rev Med Suisse; 2017 May; 13(563):1029-1031. PubMed ID: 28636292
[TBL] [Abstract][Full Text] [Related]
3. Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.
Cavalieri S; Rivoltini L; Bergamini C; Locati LD; Licitra L; Bossi P
Cancer Treat Rev; 2018 Apr; 65():78-86. PubMed ID: 29574334
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for Head and Neck Cancer.
Sim F; Leidner R; Bell RB
Oral Maxillofac Surg Clin North Am; 2019 Feb; 31(1):85-100. PubMed ID: 30449528
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy for head and neck squamous cell carcinoma].
Bron L; Romero P
Rev Med Suisse; 2006 Oct; 2(81):2216-9. PubMed ID: 17076151
[TBL] [Abstract][Full Text] [Related]
7. Novel Treatment Options in Head and Neck Cancer.
Schuler PJ; Laban S; Doescher J; Bullinger L; Hoffmann TK
Oncol Res Treat; 2017; 40(6):342-346. PubMed ID: 28521322
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Łasińska I; Kolenda T; Teresiak A; Lamperska KM; Galus Ł; Mackiewicz J
Anticancer Agents Med Chem; 2019; 19(3):290-303. PubMed ID: 30198439
[TBL] [Abstract][Full Text] [Related]
9. The promise of immunotherapy in head and neck squamous cell carcinoma.
Economopoulou P; Agelaki S; Perisanidis C; Giotakis EI; Psyrri A
Ann Oncol; 2016 Sep; 27(9):1675-85. PubMed ID: 27380958
[TBL] [Abstract][Full Text] [Related]
10. BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma.
Sánchez-Rodríguez C; Cruces KP; Riestra Ayora J; Martín-Sanz E; Sanz-Fernández R
Vaccine; 2017 Nov; 35(47):6395-6403. PubMed ID: 29029943
[TBL] [Abstract][Full Text] [Related]
11. Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck.
Young MR
Cancer Immunol Immunother; 2004 May; 53(5):375-82. PubMed ID: 14634795
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for head and neck squamous cell carcinoma.
Li Q; Prince ME; Moyer JS
Oral Oncol; 2015 Apr; 51(4):299-304. PubMed ID: 25624094
[TBL] [Abstract][Full Text] [Related]
13. Checkpoint immunotherapy in head and neck cancers.
Zolkind P; Uppaluri R
Cancer Metastasis Rev; 2017 Sep; 36(3):475-489. PubMed ID: 28836124
[TBL] [Abstract][Full Text] [Related]
14. Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
Hanna GJ; Adkins DR; Zolkind P; Uppaluri R
Oral Oncol; 2017 Oct; 73():65-69. PubMed ID: 28939078
[TBL] [Abstract][Full Text] [Related]
15. [Immunocheckpoint inhibition in head and neck squamous cell carcinoma: the current status and progress].
Huang LL; Shi YK
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):641-647. PubMed ID: 31550852
[TBL] [Abstract][Full Text] [Related]
16. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
[TBL] [Abstract][Full Text] [Related]
17. Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma.
Schutt C; Bumm K; Mirandola L; Bernardini G; Cunha N; Tijani L; Nguyen D; Cordero J; Jenkins MR; Cobos E; Kast WM; Chiriva-Internati M
Int Rev Immunol; 2012 Feb; 31(1):22-42. PubMed ID: 22251006
[TBL] [Abstract][Full Text] [Related]
18. Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy.
Saba NF; Mody MD; Tan ES; Gill HS; Rinaldo A; Takes RP; Strojan P; Hartl DM; Vermorken JB; Haigentz M; Ferlito A
Crit Rev Oncol Hematol; 2017 Jul; 115():50-58. PubMed ID: 28602169
[TBL] [Abstract][Full Text] [Related]
19. Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.
Bowles DW; McDermott JD; Jimeno A
Future Oncol; 2014 May; 10(6):1065-80. PubMed ID: 24941990
[TBL] [Abstract][Full Text] [Related]
20. Advances in tumor immune microenvironment of head and neck squamous cell carcinoma: A review of literature.
Hong Q; Ding S; Xing C; Mu Z
Medicine (Baltimore); 2024 Mar; 103(9):e37387. PubMed ID: 38428879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
